1. Home
  2. BCAX vs USNA Comparison

BCAX vs USNA Comparison

Compare BCAX & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • USNA
  • Stock Information
  • Founded
  • BCAX 2018
  • USNA 1992
  • Country
  • BCAX United States
  • USNA United States
  • Employees
  • BCAX N/A
  • USNA N/A
  • Industry
  • BCAX
  • USNA Medicinal Chemicals and Botanical Products
  • Sector
  • BCAX
  • USNA Health Care
  • Exchange
  • BCAX NYSE
  • USNA Nasdaq
  • Market Cap
  • BCAX 733.5M
  • USNA 648.2M
  • IPO Year
  • BCAX 2024
  • USNA 1996
  • Fundamental
  • Price
  • BCAX $13.00
  • USNA $31.84
  • Analyst Decision
  • BCAX Strong Buy
  • USNA Hold
  • Analyst Count
  • BCAX 6
  • USNA 1
  • Target Price
  • BCAX $39.50
  • USNA $38.00
  • AVG Volume (30 Days)
  • BCAX 327.7K
  • USNA 151.5K
  • Earning Date
  • BCAX 03-04-2025
  • USNA 02-25-2025
  • Dividend Yield
  • BCAX N/A
  • USNA N/A
  • EPS Growth
  • BCAX N/A
  • USNA N/A
  • EPS
  • BCAX N/A
  • USNA 2.83
  • Revenue
  • BCAX N/A
  • USNA $861,973,000.00
  • Revenue This Year
  • BCAX N/A
  • USNA N/A
  • Revenue Next Year
  • BCAX N/A
  • USNA $11.73
  • P/E Ratio
  • BCAX N/A
  • USNA $11.23
  • Revenue Growth
  • BCAX N/A
  • USNA N/A
  • 52 Week Low
  • BCAX $11.10
  • USNA $30.13
  • 52 Week High
  • BCAX $28.09
  • USNA $50.32
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • USNA 43.62
  • Support Level
  • BCAX N/A
  • USNA $30.92
  • Resistance Level
  • BCAX N/A
  • USNA $32.89
  • Average True Range (ATR)
  • BCAX 0.00
  • USNA 0.93
  • MACD
  • BCAX 0.00
  • USNA 0.16
  • Stochastic Oscillator
  • BCAX 0.00
  • USNA 61.96

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Share on Social Networks: